CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00474994
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:01.280908+00:00
Published At: 2016-01-20T00:00:00+00:00
Record Updated At: 2016-01-20
Results Posted At: 2016-01-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adult Malignant Fibrous Histiocytoma of Bone", "Desmoid Tumor", "Endometrial Cancer", "Ovarian Cancer", "Sarcoma", "Small Intestine Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-01-20"
protocolSection.identificationModule.nctId: "NCT00474994"
protocolSection.identificationModule.officialTitle: "A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent\u00ae, SU11248) in Non-GIST Sarcomas"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-01-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.